Opioid Crisis





NIH Leadership Outlines Interdisciplinary FY2018 Research Plan for HEAL Initiative

In a Viewpoint published in the Journal of the American Medical Association, National Institutes of Health leadership detail components of a newly released research plan for the Helping to End Addiction Long-term (HEAL) Initiative. The HEAL Initiative is a trans-NIH effort launched in April 2018 to advance national priorities in addressing the opioid crisis through science. With a focus on two primary areas - improving treatments for opioid misuse and addiction, and enhancing strategies for pain management - the plan describes a multifaceted program encompassing pre-clinical, clinical, drug repurposing, and community-based approaches.



SAMHSA Announces $196 Million Funding Opportunity for Opioid Treatment Grants to Hardest-hit States and Tribes

The Substance Abuse and Mental Health Services Administration (SAMHSA), an agency within the Department of Health and Human Services (HHS) is now accepting applications for $196 million to treat opioid use disorder through its Targeted Capacity Expansion: Medication Assisted Treatment-Prescription Drug Opioid Addiction grant program.



Wyoming Institute for Disabilites Launches New ECHO Network to Address Opioid Use in Wyoming (WY UCEDD)

Wyoming Institute for Disabilities, Wyoming's UCEDD at the University of Wyoming, launched a new ECHO integrated care network in February designed to address issues related to opioid use in Wyoming. UW ECHO in Behavioral Health is a collaboration with the Wyoming Department of Health and Mountain Plains Addiction Technology Transfer Center and brings together professionals from behavioral health, primary care, law enforcement as well as treatment and recovery providers, peer specialists and pharmacists. By sharing promising practices and evidenced-based care, the network provides participants with an opportunity to participate in an online professional community dedicated to preventing opiate addiction and fostering recovery.





Help, Resources and Information on the National Opioids Crisis from HHS

Increased prescription of opioid medications has led to widespread misuse of both prescription and non-prescription opioids before it became clear that these medications could indeed be highly addictive. This webpage offers help, resources and information on the national opioid crisis.



Treatment Resources for Opioid Use Disorder from SAMSHA

SAMHSA works with federal partners, states, and community stakeholders to develop and coordinate a comprehensive response to the opioid epidemic. SAMHSA addresses opioid use and misuse through approaches such as informing and guiding opioid prescribing practices, the expansion of medicationassisted treatment (MAT), and individual-provider decision making tools.



CMS Guidance: Addressing Neonatal Abstinence Syndrome

Medicaid services can play a critical role in helping ensure access to treatment for these vulnerable infants who have Neonatal Abstinence Syndrome (NAS). Neonatal Abstinence Syndrome (NAS) is a postnatal drug withdrawal syndrome that occurs primarily among opioid-exposed infants shortly after birth. The Centers for Medicare & Medicaid Services CMS released guidance aimed at building on our commitment to partner with states to ensure that they have flexibilities and the tools necessary to combat the opioid crisis.



Every day, more than 115 people in the United States die after overdosing on opioids.1 The misuse of and addiction to opioids-including prescription pain relievers, heroin, and synthetic opioids such as fentanyl-is a serious national crisis that affects public health as well as social and economic welfare. This page will highlight news items, resources and events regarding the opioid crisis.